Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
102.2 USD | +0.44% | -1.69% | -7.16% |
May. 30 | U.S. FDA set to reorganize its food division starting October | RE |
May. 30 | Redburn Adjusts Price Target on Abbott Laboratories to $113 From $115 | MT |
Financials (USD)
Sales 2024 * | 41.72B | Sales 2025 * | 44.73B | Capitalization | 178B |
---|---|---|---|---|---|
Net income 2024 * | 5.98B | Net income 2025 * | 7.17B | EV / Sales 2024 * | 4.39 x |
Net Debt 2024 * | 5.47B | Net Debt 2025 * | 112M | EV / Sales 2025 * | 3.98 x |
P/E ratio 2024 * |
29.6
x | P/E ratio 2025 * |
25.5
x | Employees | 114,000 |
Yield 2024 * |
2.14% | Yield 2025 * |
2.3% | Free-Float | 86.96% |
Latest transcript on Abbott Laboratories
1 day | +0.44% | ||
1 week | -1.69% | ||
1 month | -3.57% | ||
3 months | -13.87% | ||
6 months | -2.01% | ||
Current year | -7.16% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 50 | 14-12-31 |
Philip Boudreau
DFI | Director of Finance/CFO | 51 | 96-12-31 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 89-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Starks
BRD | Director/Board Member | 69 | 17-02-15 |
John Stratton
BRD | Director/Board Member | 63 | 17-06-28 |
Nancy McKinstry
BRD | Director/Board Member | 65 | 11-12-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.18% | 17 M€ | +6.09% | - | |
5.19% | 2 M€ | -.--% | ||
3.00% | 2 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 102.2 | +0.44% | 7,915,676 |
24-05-30 | 101.7 | +1.00% | 5,126,729 |
24-05-29 | 100.7 | -1.20% | 4,961,324 |
24-05-28 | 102 | -1.92% | 4,771,127 |
24-05-24 | 104 | -0.27% | 4,455,866 |
Delayed Quote Nyse, May 31, 2024 at 04:03 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.24B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- ABT Stock